In tumor models, these cells promote the growth of various tumors by suppressing immune systems or by exerting protumor activity through immuno-suppressive agents such as interleukin-10 (IL-10) and transforming growth factor-β (TGF-β). This evidence concerns the gene IL10 and neoplasm.